Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Avalanche Biotechnologies Company Profile (NASDAQ:AAVL)

Consensus Ratings for Avalanche Biotechnologies (NASDAQ:AAVL) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $50.00 (26.87% upside)

Analysts' Ratings History for Avalanche Biotechnologies (NASDAQ:AAVL)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/26/2015Jefferies GroupBoost Price TargetBuy$46.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
3/26/2015Chardan CapitalReiterated RatingHold$40.00ViewTweet This Rating  Share This Rating on StockTwits
3/26/2015Piper JaffrayBoost Price TargetOverweight$52.00ViewTweet This Rating  Share This Rating on StockTwits
3/9/2015SunTrustInitiated CoverageBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
3/9/2015Piper JaffrayReiterated RatingOverweight$47.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2015Chardan CapitalInitiated CoverageNeutral$40.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2015Jefferies GroupBoost Price TargetBuy$40.00 -> $46.00ViewTweet This Rating  Share This Rating on StockTwits
12/2/2014Piper JaffrayBoost Price Target$47.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014William BlairInitiated CoverageOutperform$52.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Cowen and CompanyInitiated CoverageOutperform$45.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Piper JaffrayInitiated CoverageOverweight$39.00ViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Jefferies GroupInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/31/2013 forward)